Retatrutide Prescribed Online to Utah Residents
Medical Weight Loss Treatment in Utah
Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).
Key Benefits
- Triple receptor mechanism: GLP-1 + GIP + glucagon for amplified metabolic effect
- Phase 2 data shows 24.2% average weight loss at 48 weeks (12mg dose)
- ~58% hepatic fat reduction in Phase 2 sub-group analyses
- Elevated basal metabolic rate via glucagon receptor agonism
- Research-grade purity ≥98% with full CoA, HPLC, and MS documentation
Who is a Good Candidate?
Intended for laboratory researchers and pre-clinical study investigators studying triple receptor agonism, obesity mechanisms, hepatic metabolism, or GLP/GIP/glucagon signaling pathways. Listed for research-use only (RUO) — not for human therapeutic use.
Available for research use
Serving Utah
Utah's stunning landscapes—from the Wasatch Range to the red rock country—deserve healthcare that's equally impressive. OmniRx Health serves the entire Beehive State, from Salt Lake's tech sector to Provo's family communities, the ski towns of Park City to the remote beauty of the Four Corners region. Our telehealth platform fits Utah's active lifestyle, providing expert care that works around your adventures and busy schedule.
OmniRx Health providers are licensed by the Utah Division of Occupational and Professional Licensing for statewide telehealth.
Utah pharmacies in Salt Lake City, Provo, and throughout the state provide prescription services with convenient delivery options.
Utah has progressive telehealth laws that support comprehensive virtual care delivery throughout the Beehive State.
Utah insurers cover telehealth services, with the state encouraging virtual care as part of its healthcare innovation agenda.
Frequently Asked Questions
- What is retatrutide and how does it work?
- Retatrutide (CAS 2381089-83-2) is a 39-amino acid synthetic peptide that simultaneously activates GLP-1, GIP, and glucagon receptors. This triple agonism produces coordinated appetite suppression (GLP-1), amplified insulin and fat-cell metabolism (GIP), and increased hepatic glucose output and resting energy expenditure (glucagon). It is currently in Phase 3 clinical trials and is available for research-use only (RUO).
- How does retatrutide compare to semaglutide and tirzepatide in research?
- Phase 2 data (NEJM, 2023) showed retatrutide at 12mg produced 24.2% average weight loss at 48 weeks, outperforming semaglutide (~15% at 68 weeks) and tirzepatide (~22% at 72 weeks) in their respective trials. Retatrutide adds glucagon receptor agonism — absent in both comparators — which appears to drive additional metabolic rate elevation and hepatic fat clearance.
- Is retatrutide available for human use?
- No. Retatrutide has not received FDA approval for any human therapeutic use. It is currently in Phase 3 (TRIUMPH) clinical trials and is listed by OmniRx strictly as a research-use only (RUO) compound for laboratory and pre-clinical research applications.
- Is telehealth legal in Utah?
- Yes, Utah has progressive telehealth laws supporting virtual healthcare. The state encourages telehealth innovation while maintaining quality and safety standards.
- Can Utah outdoor enthusiasts use telehealth?
- Telehealth is perfect for Utah's active population. Get care from your mountain cabin, between ski runs, or anywhere you have internet access.
- Does Utah insurance cover telehealth?
- Most Utah health insurance plans cover telehealth visits. The state's forward-thinking approach has encouraged insurers to embrace virtual care coverage.